SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-008952
Filing Date
2024-02-01
Accepted
2024-01-31 19:33:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm244794d1_sc13ga.htm SC 13G/A 37225
  Complete submission text file 0001104659-24-008952.txt   38559
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93555 | Film No.: 24584570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address
Shemesh Shay (Filed by) CIK: 0001896056 (see all company filings)

Type: SC 13G/A